Combined treatment with vemurafenib and cobimetinib in Langerhans cell histiocytosis and Erdheim-Chester disease overlap syndrome: A case Report
<p>Histiocytoses are clonal disorders diseases derived from the monocyte-macrophage lineage. The Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) may occur in association with overlapping clinical, histopathological and molecular features, harboring somatic MAP2K1 mutation...
Saved in:
Main Authors: | Hidalgo-Soto Marta (Author), Poza-Santaella María (Author), Pita-Suárez Daniel (Author), Calbacho-Robles María (Author), Pina-Sánchez José (Author), González-Medina José (Author), Baumann Tycho Stephan (Author) |
---|---|
Format: | Book |
Published: |
Archives of Hematology Case Reports and Reviews - Peertechz Publications,
2022-01-20.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Rare Case of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome
by: Shahzaib Nabi, et al.
Published: (2015) -
Erdheim-Chester Disease
by: Melissa Matzumura MD, et al.
Published: (2016) -
Everolimus in Erdheim-Chester disease
by: Mohamed A. Hussein, et al.
Published: (2013) -
Updates on Erdheim-Chester disease
by: Ismail Elbaz Younes, et al.
Published: (2022) -
Progressive nodular histiocytosis with dramatic response to cobimetinib
by: Philip C. Berce, PharmD, et al.
Published: (2022)